AREDS AND AREDS2, explained
What AREDS and AREDS2 were actually studied for
If you have searched for eye supplements, you have met these two acronyms. They name clinical formulations tested in large studies of age-related macular degeneration, not general vision products. The distinction is the whole point of this page.
A reading resource for families in Indonesia comparing eye-nutrition information, not a shop and not a prescription.
Common questionsStarted as a study mix
The first AREDS formula combined vitamin C, vitamin E, beta-carotene, zinc and copper. It was assembled to test one question in a defined patient group.
Revised after follow-up
AREDS2 swapped beta-carotene for lutein and zeaxanthin. Follow-up data described that version as more effective and safer, which is why it is referenced more often today.
Not a general product
Neither formula was studied for sharpening normal vision, easing screen fatigue or covering a diet low in vegetables. The boundary is the diagnosis.
The original AREDS formula
The AREDS formulation is a research-based supplement mix used in age-related eye disease studies. It was never intended as a universal eye-health supplement, and the studies were not built to test that idea.
Its five ingredients were chosen because each one was measurable, stable in a supplement, and plausible enough to test in a controlled setting. That is a research decision, not a ranking of what matters most for eye nutrition.
What the first formula contained
- Vitamin CA standard antioxidant nutrient included in the tested mix
- Vitamin EFat-soluble nutrient, paired with the carotenoid in the mix
- Beta-caroteneThe original carotenoid, later replaced in the follow-up study
- ZincA mineral already discussed in this site's nutrient guide
- CopperIncluded alongside the zinc, which is not unusual in long-term zinc dosing
Who the studies looked at
The participants were adults living with certain stages of age-related macular degeneration, typically those at higher risk of progressing to the advanced form of the condition. They were not a general sample of adults hoping to improve normal vision.
This is the single most common misunderstanding about AREDS. The formula was not built for everyone who spends long days at a screen, and it was not built for people with healthy eyes and an unremarkable last check-up. Reading the study group correctly tells you whether the formula is even a question worth asking about your own situation.
The people studied
- Adults with certain stages of AMD
- Groups judged to be at higher risk of progressing to advanced AMD
- People followed over years, not a short trial
Who was never the subject
- Adults hoping to sharpen otherwise normal vision
- People with tired or dry eyes from screen work
- Anyone using the mix to fill a vegetable-poor diet
What the research suggested
Evidence suggests the formula may reduce the risk of progressing to advanced AMD in specific patients. Note the careful wording. It is about slowing progression in an already-diagnosed group, not about preventing AMD from starting or reversing existing damage.
Medical sources do not present these formulations as a general fix for poor vision, and neither should anyone selling them. That is the honest shape of the evidence: a specific risk, in a specific group, over a long follow-up.
This page summarises published eye-nutrition research in plain language. It is educational content and does not replace advice from your own clinician.
What it addressed
Risk of progression to advanced AMD in the studied groups
What it did not address
Everyday vision sharpness, screen strain, or replacing vegetables in a diet
Who decides if it fits
A clinician, based on your stage of AMD and your medical history
What changed in AREDS2
Why the swap happened
AREDS2 replaced beta-carotene with lutein and zeaxanthin. Follow-up data described the lutein and zeaxanthin version as more effective and safer than the beta-carotene version, and that combination is now the one most often referenced in eye-nutrition writing.
Why beta-carotene became the awkward one
Beta-carotene was in the original formula and is the reason carrots carry their reputation. Once the follow-up evidence favoured the carotenoid pair on both effectiveness and safety, the older version stopped being the version people point to first.
Beta-carotene versus lutein and zeaxanthin
Original AREDS
Carried beta-carotene as its carotenoid. This is the older formulation, and the one the research has moved past as the first reference point.
AREDS2
Carried lutein and zeaxanthin instead. Follow-up data described this version as more effective and safer.
For readers in Indonesia, this is the practical takeaway from the whole AREDS story: the carotenoid pair worth knowing about is lutein and zeaxanthin, and both are easy to eat. Dark leafy greens, corn, egg yolk and mango are ordinary parts of a Jakarta or Surabaya food week.
See food sources for lutein and zeaxanthinWhy AREDS2 is not a general vision supplement
It is studied for people with certain stages of AMD. That is the boundary. It is not a formula for sharpening normal vision, easing screen fatigue, or compensating for a diet low in vegetables.
Using it outside its studied context is not supported by the research the formula comes from, regardless of what the packaging suggests. A clinician is the right person to say whether you fall inside that context, and that conversation starts long before any purchase.
If you are buying eye nutrition for general wellbeing, the useful questions are different: what you eat most weeks, what your blood work or check-up showed, and whether anything you already take overlaps with an eye supplement. The Nutrient Guide and the
Designed for a diagnosed group
Not for general eye wellness or routine sight maintenance.
Evidence is about progression
Careful wording matters: risk of progression in a group, not prevention for everyone.
A clinician sets the boundary
Stage of AMD, history and medication all sit in that conversation.
Reading a formula that says AREDS
Compare the ingredient list to the studied mix: vitamin C, vitamin E, zinc, copper, and either beta-carotene or the lutein and zeaxanthin pair. Watch for formulas that borrow the name while listing an entirely different set of ingredients, or that bury the resemblance inside a proprietary blend.
The name alone tells you very little. Ingredient order, the form of each nutrient, and whether the carotenoid is spelled out are the details that separate a studied-style mix from a label borrowing the acronym.
More on reading supplement labelsQuestions worth asking a clinician
If AMD runs in your family or you have been diagnosed, a few things are worth raising directly. Write them down before the appointment so you do not lose them in the room.
- Is my stage of AMD one the formula was studied in? This is the first question, because everything else depends on the answer. The studies worked with particular stages and risk levels, and your report should name yours.
- Beta-carotene or the lutein version for my history? Follow-up data favoured lutein and zeaxanthin on both effectiveness and safety, but your history and habits belong in that decision too.
- Does any ingredient interact with my medication? High-dose zinc, copper and the carotenoids all deserve a check against what you already take. Beta-carotene in particular deserves that conversation rather than a self-directed decision.
- Should I change what I eat first? Food is where most readers should start, and it is the cheaper conversation. Bring a rough picture of a normal week of meals, including how often greens and fish actually appear.
How this page fits with the rest of the site
AREDS2 is the most important single evidence base in eye-nutrition writing, which is why it gets a dedicated page rather than a paragraph. It still sits inside a wider picture: everyday food sources, the other nutrients discussed on this site, and the
If you arrived here first, the Nutrient Guide gives you the surrounding context on lutein, zeaxanthin, omega-3s and zinc. If a clinician has mentioned the formula to you or to a relative, this page is the one to read before any purchase.
Common questions about the formulas
Is AREDS2 a general eye supplement?
No. It was studied in people with certain stages of age-related macular degeneration, not in the general population. It is not intended for improving normal vision or for general eye wellness.
Why did AREDS2 replace beta-carotene?
AREDS2 used lutein and zeaxanthin instead of beta-carotene. Follow-up data described the lutein and zeaxanthin version as more effective and safer than the beta-carotene version.
Can I take an AREDS-style formula to prevent AMD?
The research looked at reducing the risk of progressing to advanced AMD in specific patient groups, not at preventing AMD from developing. Prevention claims go beyond what the studies support, so treat any such claim with caution.
How do I know if a product resembles a studied formula?
Compare the ingredient list with the studied mix: vitamin C, vitamin E, zinc, copper, and either beta-carotene or the lutein and zeaxanthin pair. A product using the AREDS name with an unrelated ingredient list is borrowing the label, not the research.
Still unsure whether a formula applies to your situation? Our Contact page lists the resource's working hours and email, and the editors answer questions about sources and terminology. Questions about your own diagnosis belong with your clinician, not with us.